A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a…

About this Attention Score

• In the top 25% of all research outputs scored by Altmetric
• High Attention Score compared to outputs of the same age (85th percentile)
• Above-average Attention Score compared to outputs of the same age and source (58th percentile)